Last reviewed · How we verify
NCT04305158
Colonoscopy Using Nitrous Oxide- A Pilot Study in the USA
EARLY_PHASE1 trial testing Nitrous Oxide in Nitrous Oxide in 200 participants. Completed in 10 August 2023.
10 August 2023
Quick facts
| Lead sponsor | University of Arkansas |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 200 |
| Start date | 28 March 2022 |
| Primary completion | 10 August 2023 |
| Estimated completion | 10 August 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Nitrous Oxide (NITROUS OXIDE) — full drug profile →
Conditions studied
- Nitrous Oxide — all drugs for Nitrous Oxide →
Sponsor
University of Arkansas
Who can join
18 and older, any sex, with Nitrous Oxide. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Colon cancer is the second most common cancer in men and the third most common cancer in women worldwide. The clinical objectives of administering sedation for GI endoscopy are to relieve patient anxiety and discomfort and to improve the outcome of the examination. Use of N2O could potentially provide an alternate safe and cheap option for patients who do not prefer IV sedation for colonoscopy
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04305158
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Nitrous Oxide
Trials testing the same drug.
- NCT07245628 — A Trial of Self-Adjusted Nitrous Versus Placebo During Office Vasectomy · EARLY_PHASE1 · recruiting
- NCT05890898 — Virtual Reality vs Nitrous Oxide in Pediatric Dentistry · NA · completed
- NCT04378426 — Nitrous Oxide for PTSD · Phase 2 · terminated
- NCT04884893 — Effect of Nitrous Oxide on EEG · Phase 1 · completed
- NCT04124562 — Nitrous Oxide Frequency of Use and Causes in Hospital in Turkey · completed
Other recruiting trials for Nitrous Oxide
Currently open trials in the same condition.
- NCT06636357 — Nitrous Oxide in the Treatment of Acute Suicidal Ideation · Phase 2 · recruiting
Other University of Arkansas trials
Trials by the same sponsor.
- NCT07029776 — MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma · Phase 2 · not yet recruiting
- NCT07341399 — Essential Amino Acid Supplementation in Adult Spinal Deformity Patients · NA · not yet recruiting
- NCT07071766 — Improving Outcomes for Early Postpartum Mothers in Outpatient MOUD Treatment · NA · recruiting
- NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
- NCT06604065 — Essential Amino Acids and Parkinsons Disease · Phase 1 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04305158 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Arkansas
- Last refreshed: 11 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04305158.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing